You are viewing: France Humanized Mouse and Rat Model Market analysis

The France Humanized Mouse and Rat Model Market was valued at $12.4 Million in 2025 and projected to reach to $18.6 Million by 2030, representing a compound annual growth rate of 8.6%. France's humanized mouse and rat model market is poised for sustained expansion driven by increasing investments in preclinical research infrastructure and the country's commitment to advancing personalized medicine.

France Humanized Mouse and Rat Model Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Humanized Mouse and Rat Model Market Trends and Insights

  • This expansion reflects France's strong position in preclinical research and drug development, supported by leading pharmaceutical and biotechnology institutions across the country.
  • France's commitment to advancing personalized medicine and translational research is driving demand for sophisticated animal models that better replicate human biology. The French market benefits from significant investment in life sciences infrastructure and a highly skilled research workforce dedicated to improving drug efficacy and safety testing.
  • France's regulatory environment and collaborative research ecosystem continue to foster innovation in humanized model development.
  • Between 2025 and 2030, France is expected to see accelerated adoption of these models in oncology, immunology, and infectious disease research, positioning the country as a key contributor to European preclinical research advancement..

Key Market Statistics

  • CAGR (2025-2030) 8.6% CAGR
  • Market Size, 2025 ~USD 12.4 Million
  • Forecast, 2030 ~USD 18.6 Million
  • Country France

France Humanized Mouse and Rat Model Market Overview

Market Valuation :

France's humanized mouse and rat model market is valued at $12.4 million in 2025, with strong growth trajectory reaching $18.6 million by 2030, representing a robust 8.6% CAGR.

Research Infrastructure :

France hosts world-class pharmaceutical and biotechnology institutions that drive demand for advanced preclinical research models, positioning the country as a key hub for drug development in Europe.

Personalized Medicine Focus :

French research institutions are increasingly adopting humanized models to advance personalized medicine initiatives, enhancing the accuracy of preclinical testing and reducing time-to-market for therapeutics.

Growth Outpacing Global Average :

France's market CAGR of 8.6% exceeds the global average of 8.2%, indicating accelerating adoption of humanized animal models among French pharmaceutical and academic research organizations.

France Humanized Mouse and Rat Model Market Dynamics

  • Leading French pharmaceutical companies and research institutions are leveraging these models to accelerate drug discovery pipelines and improve clinical trial outcomes.
  • The market benefits from strong government support for life sciences innovation and collaborative research initiatives across academic and commercial sectors. Looking ahead to 2030, France's market growth will be fueled by rising demand for more predictive preclinical models, regulatory emphasis on reducing animal testing through better alternatives, and expanding applications in oncology, immunology, and rare disease research.
  • Strategic partnerships between French biotech firms and international pharmaceutical companies will further drive market penetration and technological advancement in humanized model development..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • France's humanized mouse and rat model market is valued at $12.4 million in 2025 and will reach $18.6 million by 2030, representing an 8.6% CAGR.
    • France's robust pharmaceutical and biotechnology sector drives strong demand for advanced preclinical research models.
    • France's investment in life sciences infrastructure and skilled research talent accelerates adoption of humanized models across therapeutic areas.
    • France is positioned as a key European hub for translational research and personalized medicine development through 2030.

    Humanized Mouse and Rat Model Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS AND CDMOS) (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.2% from 2025 to 2030
    Largest Segment HUMANIZED MOUSE MODELS (Type)
    Market Size Base Year (Billions) ~USD 0.28 (2025)
    Revenue Forecast (Billions) ~USD 0.41 (2030)
    Segments Covered Type, End User, Application

    France Humanized Mouse and Rat Model Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Type

    • Blt Humanized Mouse Models
    • Cd34 Humanized Mouse Models
    • Cell-Based Humanized Mouse Models
    • Genetic Humanized Mouse Models
    • Humanized Mouse Models
    • Humanized Rat Models
    • Pbmc Humanized Mouse Models

    By End User

    • Academic & Research Institutes
    • Academic And Research Institutes
    • Contract Research Organizations And Contract Development And Manufacturing Organizations (Cros And Cdmos)
    • Cros & Cdmos
    • Cros And Cdmos
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical And Biotechnology Companies

    By Application

    • Hematopoiesis
    • Immunology And Infectious Diseases
    • Neuroscience
    • Oncology
    • Other Applications
    • Toxicology

    FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES2.12.22.32.42.62.72.935.8
    CROS AND CDMOS3.53.84.14.555.566.59.7
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES7.88.18.89.510.311.11212.98
    TOTAL13.514.115.216.517.919.320.822.58.2

    Target Audience

    • French Pharmaceutical Companies : Need market intelligence to optimize preclinical research investments, benchmark against competitors, and identify opportunities to integrate humanized models into drug development pipelines.
    • Biotech & Research Institutions : Require detailed market data to justify funding requests, understand adoption trends among peers, and strategically position their humanized model capabilities within France's research ecosystem.
    • Contract Research Organizations (CROs) : Need France-specific market insights to develop service offerings, identify growth opportunities, and understand demand patterns from local pharmaceutical and biotech clients.
    • Model Suppliers & Vendors : Require market sizing and growth forecasts specific to France to develop go-to-market strategies, allocate sales resources, and identify key customer segments in the French market.
    • Investment & Venture Capital Firms : Need comprehensive France market data to evaluate investment opportunities in biotech startups, assess market potential, and make informed funding decisions in the preclinical research space.

    Key Companies in the France Humanized Mouse and Rat Model Market

    CompanyHQOwnershipStrongest segments
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    THE JACKSON LABORATORYUnited StatesFoundation/Charitable InstitutionMouse breeding and colony management,Phenotyping, efficacy testing, and genetic research services,Genetic resources, software, and data,
    INOTIVUnited StatesPublic CompanyResearch Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
    GENOWAYFrancePublic CompanyCustom mouse models (KO/KI and humanized),Custom rat models,Engineered cell lines,
    JSR CORPORATIONJapanPrivate CompanyDigital Solutions (lithography, photoresists, CMP, display and packaging materials),Plastics / Synthetic Resins (ABS, AES, AS, ASA and related resins),Life Sciences (diagnostic and research reagents, bioprocess materials, drug discovery support),
    CHAMPIONS ONCOLOGY, INC.United StatesPublic CompanyTumorgraft / PDX-based translational oncology services,Personalized cancer care services,Lumin Bioinformatics and data-driven software,
    ONCODESIGN SERVICESFrancePublic CompanyPrecision oncology and immuno-oncology (OPM-101, OPM-102),Neurodegeneration (OPM-201, Parkinson’s),Radiotheranostic portfolio for digestive and pancreatic cancers,

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a public company founded in 1947 in the United States with 19,000 employees.

    THE JACKSON LABORATORY

    The Jackson Laboratory is a foundation-based charitable institution founded in 1929 in the United States with 2,100 employees.

    INOTIV

    Inotiv is a public company founded in 1974 in the United States with 1,996 employees.

    GENOWAY

    Genoway is a public company founded in 1999 in France with 157 employees.

    JSR CORPORATION

    JSR Corporation is a private company founded in 1948 in Japan with 7,997 employees.

    CHAMPIONS ONCOLOGY, INC.

    Champions Oncology, Inc. is a public company founded in 1985 in the United States with 214 employees.

    ONCODESIGN SERVICES

    Oncodesign Services is a public company founded in 1995 in France.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for France's humanized model market with detailed 2025-2030 projections, enabling accurate budget allocation and investment planning specific to the French market landscape.
    • Competitive Intelligence : Understand France's market dynamics relative to global trends, with insights into local pharmaceutical and biotech players driving adoption of humanized models in preclinical research.
    • Regulatory & Infrastructure Insights : Gain detailed knowledge of France's research infrastructure, regulatory environment, and institutional support systems that influence humanized model adoption and market growth trajectories.
    • Strategic Partnership Opportunities : Identify key French research institutions, pharmaceutical companies, and biotech firms actively investing in humanized models, enabling targeted business development and collaboration strategies.
    • Growth Driver Analysis : Understand France-specific factors driving 8.6% CAGR, including personalized medicine initiatives, drug development acceleration, and regulatory pressures shaping market demand.

    Frequently asked questions

    What is the current market size of humanized mouse and rat models in France?

    France's humanized mouse and rat model market was valued at $12.4 million in 2025 and is expected to grow to $18.6 million by 2030.

    What is the projected growth rate for France's humanized model market?

    France's market is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

    Which therapeutic areas are driving demand for humanized models in France?

    France is seeing increased adoption of humanized models in oncology, immunology, and infectious disease research, supported by the country's advanced research institutions.

    Why is France a significant market for humanized animal models?

    France's strong pharmaceutical and biotechnology sector, combined with substantial investment in life sciences infrastructure and a skilled research workforce, makes it a key market for preclinical research innovation.

    What factors support growth in France's humanized model market through 2030?

    France's commitment to personalized medicine, translational research initiatives, regulatory support, and collaborative research ecosystem are key drivers of market expansion between 2025 and 2030.

    RESEARCH METHODOLOGY

    The research study used secondary sources, directories, and databases to identify and collect valuable information to analyze the global humanized mouse and rat model market. Widespread interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size was estimated through secondary research (top-down and bottom-up), followed by data triangulation with inputs from industry experts to determine the final market size.

    Secondary Research

    Secondary research was used to identify and collect information for the technical, market-oriented, and commercial study of the humanized mouse and rat model market. The secondary sources used for this study include the American Association for Cancer Research (AACR), American Association for Laboratory Animal Science (AALAS), European Society for Medical Oncology (ESMO), European Association for Cancer Research (EACR), Humanized Mouse Resource (HMR), National Center for Biotechnology Information (NCBI), and Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

    Academic Journals and Company Websites; corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations were also used to obtain major information about key market players and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analyzed to determine the market size of the global humanized mouse and rat model market, which was further validated through primary research.

    Primary Research

    Primary research was conducted after acquiring basic knowledge about the global humanized mouse and rat model market through secondary research. A series of primary interviews were conducted with market experts from the demand side, including professionals from the pharmaceutical and biopharmaceutical industries and academic institutions. Additionally, interviews were held with individuals from the supply side, such as C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners. The primary interviews were conducted across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants. This data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The breakdown of the primary respondents is given below.

    Humanized Mouse and Rat Model Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Top-down and bottom-up approaches were used to estimate and validate the total size of the humanized mouse and rat model market. These methods were also used extensively to estimate the size of various subsegments in the market.

    Humanized Mouse and Rat Model Market

    Data Triangulation

    After determining the market size from the above estimation process, the total market was divided into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides.

    Market Definition

    A humanized mouse and rat model is an immunodeficient organism genetically engineered to study immune responses to drugs or identify potential disease targets. These models are widely used to study human diseases and genes. Researchers in both academia and industry, along with clinicians, extensively use humanized mouse and rat models in their research applications. Humanized mouse and rat models are beneficial tools for immuno-oncology and infectious disease research. They have improved the ability to predict human responses to new therapeutics in clinical development.

    Stakeholders

    • Research and consulting firms
    • Biopharmaceutical manufacturers
    • Pharmaceutical manufacturers
    • Mouse model and service companies
    • Government and private research institutes
    • Manufacturers and suppliers of animal care products
    • Clinical research organizations (CROs)
    • Academic and research institutes
    • Venture capitalists
    • Laboratory animal care associations
    • Public and private animal health agencies

    Report Objectives

     

    To define, describe, and forecast the humanized mouse and rat model market by type, application, end user, and region

    To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)

    • To analyze the micromarkets1 concerning individual growth trends, prospects, and contributions to the overall humanized mouse and rat model market
    • To assess the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments for North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
    • To profile the key players and analyze their market shares and core competencies2
    • To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

     

    Get the Full Humanized Mouse and Rat Model Market Report

    Full forecast, segment splits, and company analysis for all Humanized Mouse and Rat Model Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status